Thomas Zilli
@zillithomas
Radiation Oncology, IOSI - Oncology Institute of Southern Switzerland, EOC, Switzerland
ID: 1041422567393959938
16-09-2018 20:24:23
2,2K Tweet
1,1K Followers
964 Following
The endless debate in patients with BCR after radical treatment: Do Not EMBARK on When, If the Answer Is How | Journal of Clinical Oncology . ascopubs.org/doi/10.1200/JC… Gianluca Giannarini
Just in The Lancet Oncology 👉Zr-girentuximab PET–CT is highly accurate for detecting ccRCC #kidneycancer (like PSMA-PET in prostate ca) Congrats, Brian Brian Shuch, MD et al, on these practice-impacting data. Open access👉tinyurl.com/4cwkm8u5 Michael Morris OncoAlert UroToday.com
⚡️ Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer #BladderCancer BJU International bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…
#PACE A published in European Urology! SBRT vs Radical prostatectomy. Spread the word #SBRT should be discussed with eligible patients Dr Shaun Tolan Alison Tree 💙 Clive Peedell Dr. Andrew Loblaw Prof Emma Hall Prof Joe O'Sullivan authors.elsevier.com/sd/article/S03…
PFS and OS advantage of radium-223 + Enza vs Enza alone in metastatic prostate cancer—-new combo on the horizon —congrats silke gillessen and PEACE-3 team. No increased SREs! ESMO - Eur. Oncology #ESMO2024
Outstanding talk from silke gillessen elegantly presenting PEACE-3 phase 3 trials first results. Adding 6 cycles of Ra223 to enzalutamide as first-line therapy for mCRPC showed significant rPFS improvement + significant OS benefit #ESMO24 ESMO - Eur. Oncology OncoAlert UroToday.com
Prof Silke Gillessen silke gillessen presenting at #ESMO24 the results of stampede Arm K. Addition of Metformin has a clear benefit on metabolic effects on the long term. Look into the high volume subgroup outcomes in detail, interesting results!
Thomas Kennedy leads 10y prostate #SBRT outcomes from 3 different prospective studies now epub at #RedJ IJROBP - The Red Journal doi.org/10.1016/j.ijro… Great biochemical control to 15 years and only 1% chance of mets! Note 10% of UIR pts received ADT and none had whole pelvic RT (-> #PR24)
Pleased to share the newest MARCAP publication, out in European Urology -- the TRANSPORT analysis of T recovery after ADT for localized PCa, led by Wee Loon Ong and Tahmineh Romero Free share link: authors.elsevier.com/a/1joOX14kplyz…